XORTX THERAPEUTICS INC (XRTX)
CA98420Q3061 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.16M | -7.00M | -1.22M | -948.53K | -629.58K | |||
| Depreciation Amortization | 139.69K | 58.15K | 13.18K | 15.26K | 19.90K | |||
| Change In Working Capital | -1.03M | 1.47M | -1.01M | 270.49K | 298.08K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | N/A | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | N/A | |||
| Other non cash items | -3.53M | -2.78M | -2.25M | 129.60K | 62.02K | |||
| OPERATING CASH FLOW | -6.58M | -8.96M | -4.47M | -543.95K | -249.58K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -46.36K | -45.70K | -29.34K | -10.72K | -7.04K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -46.36K | -45.70K | -29.34K | -10.72K | -7.04K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -66.09K | -20.41K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 300.00 | 5.00M | 18.66M | 672.09K | 70.00K | |||
| Other Financing Activity | -295.25K | -269.56K | -631.02K | -33.30K | -14.79K | |||
| FINANCING CASH FLOW | -361.04K | 4.71M | 18.03M | 638.79K | 55.21K | |||
| Exchange Rate Effect | 4.04K | -136.15K | 240.10K | N/A | N/A | |||
| CHANGE IN CASH | -6.99M | -4.44M | 13.77M | 84.13K | -201.41K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.58M | -8.96M | -4.47M | -543.95K | -249.58K | |||
| Capital Expenditure | -46.36K | -45.70K | -29.34K | -10.72K | -7.04K | |||
| FREE CASH FLOW | -6.63M | -9.01M | -4.50M | -554.66K | -256.62K | |||
All data in USD